These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13130409)

  • 1. Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
    Rhew DC; Bernal M; Aguilar D; Iloeje U; Goetz MB
    Clin Infect Dis; 2003 Oct; 37(7):959-72. PubMed ID: 13130409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
    Iloeje UH; Yuan Y; L'italien G; Mauskopf J; Holmberg SD; Moorman AC; Wood KC; Moore RD
    HIV Med; 2005 Jan; 6(1):37-44. PubMed ID: 15670251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management.
    Neto MG; Zwirtes R; Brites C
    Braz J Infect Dis; 2013; 17(6):691-700. PubMed ID: 23916459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Efficacy and Safety of Adding Ezetimibe to Current Regimen of Lipid-Lowering Drugs in Human Immunodeficiency Virus-Infected Thai Patients Treated with Protease Inhibitors.
    Boonthos K; Puttilerpong C; Pengsuparp T; Manosuthi W
    Jpn J Infect Dis; 2018 May; 71(3):220-224. PubMed ID: 29709973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort.
    Vaughn G; Detels R
    AIDS Care; 2007 Apr; 19(4):492-9. PubMed ID: 17453589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of antiretroviral drugs: clinical review.
    Filardi PP; Paolillo S; Marciano C; Iorio A; Losco T; Marsico F; Scala O; Ruggiero D; Ferraro S; Chiariello M
    Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):238-44. PubMed ID: 19075633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary protease inhibitors and cardiovascular risk.
    Lundgren J; Mocroft A; Ryom L
    Curr Opin Infect Dis; 2018 Feb; 31(1):8-13. PubMed ID: 29232276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function.
    Sun D; Wu Y; Yuan Y; Wang Y; Liu W; Yang J
    Atherosclerosis; 2015 Sep; 242(1):109-16. PubMed ID: 26188532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor-sparing simplified maintenance therapy: a need for perspective.
    Bucher HC; Young J; Battegay M
    J Antimicrob Chemother; 2004 Aug; 54(2):303-5. PubMed ID: 15269200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
    Crane HM; Van Rompaey SE; Kitahata MM
    AIDS Patient Care STDS; 2007 Dec; 21(12):920-9. PubMed ID: 18154489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system.
    Reyskens KM; Essop MF
    Biochim Biophys Acta; 2014 Feb; 1842(2):256-68. PubMed ID: 24275553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease inhibitors.
    Eron JJ
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S160-70. PubMed ID: 10860901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular considerations in patients treated with HIV protease inhibitors.
    Colagreco JP
    J Assoc Nurses AIDS Care; 2004; 15(1):30-41. PubMed ID: 14983559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIs associated with increased risk of cardiovascular disease.
    Carter M
    IAPAC Mon; 2005 Feb; 11(2):37. PubMed ID: 15971352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
    Colafigli M; Di Giambenedetto S; Bracciale L; Tamburrini E; Cauda R; De Luca A
    HIV Med; 2008 Mar; 9(3):172-9. PubMed ID: 18217998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
    Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E;
    Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.